あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/05/18 | 日証協 | 236,500株 | -9.21% | 2,800株 | -96.69% | 252,256株 | +3.45% | 73,515株 | -47.27% |
2018/05/11 | 日証協 | 260,500株 | -0.8% | 84,600株 | +195.8% | 243,841株 | +49.35% | 139,407株 | +980.67% |
2018/05/02 | 日証協 | 262,600株 | -2.52% | 28,600株 | -68.01% | 163,270株 | -10.67% | 12,900株 | -78.17% |
2018/04/27 | 日証協 | 269,400株 | +28.41% | 89,400株 | +139.68% | 182,770株 | +10.34% | 59,100株 | +106.59% |
2018/04/20 | 日証協 | 209,800株 | -10.99% | 37,300株 | -69.67% | 165,641株 | -16.11% | 28,608株 | -82.65% |
2018/04/13 | 日証協 | 235,711株 | +21.93% | 123,000株 | +18.96% | 197,444株 | -13.6% | 164,900株 | +279.02% |
2018/04/06 | 日証協 | 193,311株 | -11.25% | 103,400株 | +25.05% | 228,518株 | -4.16% | 43,507株 | -74.63% |
2018/03/30 | 日証協 | 217,811株 | +37.61% | 82,687株 | -32.73% | 238,434株 | +84.93% | 171,511株 | +147.49% |
2018/03/23 | 日証協 | 158,279株 | +23% | 122,911株 | +34.84% | 128,934株 | +6% | 69,300株 | -14.34% |
2018/03/16 | 日証協 | 128,679株 | -10.32% | 91,155株 | -36.37% | 121,634株 | -8.72% | 80,900株 | +104.29% |
2018/03/09 | 日証協 | 143,479株 | +43.94% | 143,255株 | +188.24% | 133,261株 | +7.5% | 39,600株 | +127.59% |
2018/03/02 | 日証協 | 99,679株 | -6.82% | 49,700株 | -56.33% | 123,961株 | -8.35% | 17,400株 | -19.07% |
2018/02/23 | 日証協 | 106,979株 | -0.35% | 113,800株 | +10.71% | 135,261株 | +5.05% | 21,500株 | -34.87% |
2018/02/16 | 日証協 | 107,357株 | -30.68% | 102,793株 | +5.3% | 128,761株 | -23.34% | 33,011株 | -35.53% |
2018/02/09 | 日証協 | 154,871株 | -3.13% | 97,615株 | +15.52% | 167,965株 | +7.84% | 51,200株 | +103.05% |
2018/02/02 | 日証協 | 159,879株 | +0.13% | 84,500株 | +33.91% | 155,758株 | +1.37% | 25,215株 | +85.4% |
2018/01/26 | 日証協 | 159,679株 | -0.01% | 63,100株 | -24.36% | 153,658株 | -0.45% | 13,600株 | +11.07% |
2018/01/19 | 日証協 | 159,690株 | +30.8% | 83,426株 | -4.15% | 154,358株 | -1.21% | 12,245株 | -25.97% |
2018/01/12 | 日証協 | 122,090株 | +7.48% | 87,034株 | +138.41% | 156,243株 | -8.31% | 16,540株 | +65.4% |
※株式分割は考慮していませんのでご注意ください。
Page Top